HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ineffective elimination of Leishmania major by inflammatory (MRP14-positive) subtype of monocytic cells.

Abstract
Myeloid-related protein (MRP) 14, an intracellular protein involved in calcium-dependent activation of myeloid cells, presents a differentiation marker for a subtype of macrophages. In experimental leishmaniasis, BALB/c mice succumb to visceral dissemination after infection with L. major, due to a Th2 cell response, while C57Bl/6 mice develop protective immunity associated with a Th1 cell response. We have previously shown that resistance in (C57Bl/6 mice was also associated with a significantly lower percentage of MRP14-positive cells in the infiltrate than in susceptible BALB/c mice. In C57Bl/6 mice, weekly injections of bone marrow (BM) cells enriched with MRP14-positive cells (d1 of culture) did not reverse, but prolonged the course of infection, associated with increased local parasite spread. In BALB/c mice a single dose of an antiphlogistic agent (dexamethasone or lipoxygenase inhibitor) was associated with reduction of infiltrating MRP14-positive cells and also with a decrease of parasite loads in footpads, lymph nodes as well as spleens, and with delayed progression of disease, Double labeling experiments in vitro revealed that at least 43.1% of MRP14-positive mononuclear cells in BM cultures (8h) had phagocytosed parasites after 4 h of co-incubation. Activation by IFN-gamma (20 U/ml) for 24h and 48h did not significantly reduce parasite load in these cells. In contrast, 77.0% of F4/80-positive macrophages (6d of culture) were infected with L. major parasites and these cells responded to activation with IFN-gamma (20 U/ml) with significant reduction of parasite load (25.3%). The protein MRP14 did not have an effect on parasite survival in vitro. Thus, the impaired capability of MRP14-positive cells to kill L. major upon stimulation may be one reason for the adverse course of infection observed with their increased appearance.
AuthorsK Steinbrink, F Schönlau, U Rescher, U Henseleit, T Vogel, C Sorg, C Sunderkötter
JournalImmunobiology (Immunobiology) Vol. 202 Issue 5 Pg. 442-59 (Nov 2000) ISSN: 0171-2985 [Print] Netherlands
PMID11205374 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Antigens, Differentiation
  • Calgranulin B
  • Quinolines
  • S100 Proteins
  • monocyte-macrophage differentiation antigen
  • 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid
  • Dexamethasone
  • Interferon-gamma
Topics
  • Animals
  • Anti-Inflammatory Agents (administration & dosage)
  • Antigens, Differentiation (analysis, pharmacology)
  • Calgranulin B
  • Cells, Cultured
  • Dexamethasone (administration & dosage)
  • Disease Models, Animal
  • Female
  • Immunohistochemistry
  • In Vitro Techniques
  • Interferon-gamma (pharmacology)
  • Leishmania major (drug effects, pathogenicity)
  • Leishmaniasis, Cutaneous (drug therapy, immunology, parasitology)
  • Lymph Nodes (parasitology)
  • Macrophages (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Microscopy, Fluorescence
  • Monocytes (immunology)
  • Phagocytosis
  • Quinolines (administration & dosage)
  • S100 Proteins (analysis, pharmacology)
  • Spleen (parasitology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: